System and method for non-invasive monitoring of hemoglobin
AssigneeMedtronic Monitoring, Inc.
InventorRodolphe Katra
Life of this patent
Estimating the term…
Abstract
A method of non-invasively monitoring hemoglobin concentration includes providing incident light to patient tissue at a first excitation wavelength. The method further includes monitoring a first emission response at a first emission wavelength, wherein the first emission wavelength is selected to correspond with a maximum of the emission response, and monitoring a second emission response at a second emission wavelength, wherein the second emission wavelength is selected to correspond with a minimum of the emission response. A hemoglobin concentration is calculated based on a ratio of the first emission response to the second emission response.
Claims25
A system comprising.
- a medical device comprising:
- one or more light sources configured to provide incident light to a patient at a first excitation wavelength and a second excitation wavelength;
- and
- a photodetector configured to:
- monitor emissions in response to the first excitation wavelength at an emission wavelength;
- and
- monitor emissions in response to the second excitation wavelength at the emission wavelength;
- and
- one or more processors configured to determine a physiological parameter based on a ratio of emissions at the emission wavelength monitored in response to the first excitation wavelength and emissions at the emission wavelength monitored in response to the second excitation wavelength.
A method performed by a medical device comprising processing circuitry and being configured to determine a physiological parameter of a patient, the method comprising:
- providing incident light, by one or more light sources of the medical device, to the patient at a first excitation wavelength;
- monitoring emissions, by one or more photodetectors of the medical device, in response to the first excitation wavelength at an emission wavelength;
- providing incident light, by the one or more light sources, to the patient at a second excitation wavelength;
- monitoring emissions, by the one or more photodetectors, in response to the second excitation wavelength at the emission wavelength;
- and
- determining, by the processing circuitry, the physiological parameter based on a ratio of emissions at the emission wavelength monitored in response to the first excitation wavelength and emissions at the emission wavelength monitored in response to the second excitation wavelength.
Dependencies are inferred from the claim text.